|Chemical Name||florbetapir F 18|
|Dosage Form||Injection (intravenous; 500-1900 MBq/mL)|
|Drug Class||Radioactive diagnostic agents|
|Company||Eli Lilly and Company|
- Indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.